Collaborations and partnerships are an essential part of NOXXON's business strategy. The Company retains all rights to its development programs, providing a platform for strategic partnering of its non-cancer clinical and pre-clinical assets.

NOXXON collaborates with many academic investigators worldwide. The list below contains some of NOXXON's scientific advisors and collaborators.

 


Merck & Co. / MSD


National Center for Tumor Diseases (NCT)



 

This email address is being protected from spambots. You need JavaScript enabled to view it.
CEO

e-mail: This email address is being protected from spambots. You need JavaScript enabled to view it.
telephone: +49 30 726247 0
fax: +49 30 726247 225